Drugs / human neural stem cell
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT03128450 | Apr 2017 → Jun 2018 | Parkinson disease | Second Affiliated Hospital of Soochow University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | human neural stem cell | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03128450 ↗ |
| Modality | Cell therapy | “h-NSC is a cellular therapeutic consisting of human fetal neural stem cells (h-NSC).” NCT03128450 ↗ |
| Route | Intranasal | “h-NSC injection will be delivered through nasal way for patients with Parkinson's disease (PD).” NCT03128450 ↗ |